A Long Term Study of GK530G in Subjects With Acne Vulgaris

Trial Profile

A Long Term Study of GK530G in Subjects With Acne Vulgaris

Phase of Trial: Phase III

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Adapalene/benzoyl peroxide (Primary)
  • Indications Acne vulgaris
  • Focus Adverse reactions
  • Sponsors Galderma
  • Most Recent Events

    • 05 Jul 2016 According to a Galderma Pharma media release, based on this and other trial (700241693) the Japan Ministry of Health, Labor and Welfare has approved Epiduo, a for the treatment of acne vulgaris in Japan.
    • 04 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Sep 2013 Planned end date changed from 1 Jan 2015 to 1 Aug 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top